vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $16.1M, roughly 2.0× Fortress Biotech, Inc.). On growth, SOUTHERN FIRST BANCSHARES INC posted the faster year-over-year revenue change (26.1% vs 6.3%). Over the past eight quarters, SOUTHERN FIRST BANCSHARES INC's revenue compounded faster (22.2% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

FBIO vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
2.0× larger
SFST
$31.8M
$16.1M
FBIO
Growing faster (revenue YoY)
SFST
SFST
+19.9% gap
SFST
26.1%
6.3%
FBIO
Faster 2-yr revenue CAGR
SFST
SFST
Annualised
SFST
22.2%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
SFST
SFST
Revenue
$16.1M
$31.8M
Net Profit
$-3.9M
Gross Margin
66.1%
Operating Margin
-28.8%
40.1%
Net Margin
-24.5%
Revenue YoY
6.3%
26.1%
Net Profit YoY
41.8%
EPS (diluted)
$-0.15
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
SFST
SFST
Q4 25
$16.1M
$31.8M
Q3 25
$17.6M
$31.1M
Q2 25
$16.4M
$28.6M
Q1 25
$13.1M
$26.5M
Q4 24
$15.1M
$25.2M
Q3 24
$14.6M
$23.8M
Q2 24
$14.9M
$23.1M
Q1 24
$13.0M
$21.3M
Net Profit
FBIO
FBIO
SFST
SFST
Q4 25
$-3.9M
Q3 25
$5.8M
$8.7M
Q2 25
$15.5M
$6.6M
Q1 25
$-10.6M
$5.3M
Q4 24
$-6.8M
Q3 24
$-12.9M
$4.4M
Q2 24
$-10.9M
$3.0M
Q1 24
$-15.4M
$2.5M
Gross Margin
FBIO
FBIO
SFST
SFST
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
SFST
SFST
Q4 25
-28.8%
40.1%
Q3 25
-38.6%
36.4%
Q2 25
-222.2%
30.0%
Q1 25
-169.9%
26.1%
Q4 24
-158.3%
27.3%
Q3 24
-151.0%
24.1%
Q2 24
-186.5%
17.0%
Q1 24
-280.6%
15.9%
Net Margin
FBIO
FBIO
SFST
SFST
Q4 25
-24.5%
Q3 25
33.2%
27.8%
Q2 25
94.4%
23.0%
Q1 25
-80.6%
19.9%
Q4 24
-44.7%
Q3 24
-88.0%
18.4%
Q2 24
-73.5%
13.0%
Q1 24
-118.3%
11.8%
EPS (diluted)
FBIO
FBIO
SFST
SFST
Q4 25
$-0.15
$1.19
Q3 25
$0.11
$1.07
Q2 25
$0.45
$0.81
Q1 25
$-0.48
$0.65
Q4 24
$-0.16
$0.69
Q3 24
$-0.76
$0.54
Q2 24
$-0.73
$0.37
Q1 24
$-1.04
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$79.4M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$368.7M
Total Assets
$185.5M
$4.4B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
SFST
SFST
Q4 25
$79.4M
Q3 25
$86.2M
Q2 25
$74.4M
Q1 25
$91.3M
Q4 24
$57.3M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
SFST
SFST
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
SFST
SFST
Q4 25
$49.9M
$368.7M
Q3 25
$55.9M
$356.3M
Q2 25
$43.9M
$345.5M
Q1 25
$22.3M
$337.6M
Q4 24
$22.7M
$330.4M
Q3 24
$21.2M
$326.5M
Q2 24
$17.9M
$318.7M
Q1 24
$23.0M
$315.3M
Total Assets
FBIO
FBIO
SFST
SFST
Q4 25
$185.5M
$4.4B
Q3 25
$181.4M
$4.4B
Q2 25
$159.9M
$4.3B
Q1 25
$178.1M
$4.3B
Q4 24
$144.2M
$4.1B
Q3 24
$127.1M
$4.2B
Q2 24
$145.7M
$4.1B
Q1 24
$164.6M
$4.1B
Debt / Equity
FBIO
FBIO
SFST
SFST
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
SFST
SFST
Operating Cash FlowLast quarter
$-12.5M
$30.5M
Free Cash FlowOCF − Capex
$29.9M
FCF MarginFCF / Revenue
93.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
SFST
SFST
Q4 25
$-12.5M
$30.5M
Q3 25
$-6.1M
$14.5M
Q2 25
$-27.6M
$10.5M
Q1 25
$-19.6M
$7.6M
Q4 24
$-12.9M
$25.6M
Q3 24
$-20.1M
$26.3M
Q2 24
$-21.8M
$4.0M
Q1 24
$-25.4M
$-2.9M
Free Cash Flow
FBIO
FBIO
SFST
SFST
Q4 25
$29.9M
Q3 25
$14.4M
Q2 25
$10.4M
Q1 25
$7.4M
Q4 24
$24.8M
Q3 24
$26.1M
Q2 24
$3.9M
Q1 24
$-3.2M
FCF Margin
FBIO
FBIO
SFST
SFST
Q4 25
93.8%
Q3 25
46.3%
Q2 25
36.3%
Q1 25
28.1%
Q4 24
98.2%
Q3 24
110.0%
Q2 24
16.8%
Q1 24
-15.0%
Capex Intensity
FBIO
FBIO
SFST
SFST
Q4 25
1.8%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
3.1%
Q3 24
0.0%
0.8%
Q2 24
0.4%
Q1 24
1.3%
Cash Conversion
FBIO
FBIO
SFST
SFST
Q4 25
Q3 25
-1.04×
1.67×
Q2 25
-1.78×
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×
Q1 24
-1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons